Clinical Trial Details
| Trial ID: | L0352 |
| Source ID: | NCT01427907 |
| Associated Drug: | Calcium Acetate Oral Solution (Cos) |
| Title: | Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients |
| Acronym: | COS-002 |
| Status: | COMPLETED |
| Study Results: | YES |
| Results: | https://ClinicalTrials.gov/show/NCT01427907/results |
| Conditions: | Chronic Kidney Disease |
| Interventions: | DRUG: Calcium acetate oral solution (COS)|DRUG: Sevelamer carbonate |
| Outcome Measures: | Primary: Serum Phosphorus Levels, The average phosphorus level of non-missing laboratory assessments from the last two weeks of each treatment period for each subject, 2 weeks | |
| Sponsor/Collaborators: | Sponsor: Fresenius Medical Care North America |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 38 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2011-09 |
| Completion Date: | 2012-07 |
| Results First Posted: | 2016-01-14 |
| Last Update Posted: | 2016-01-14 |
| Locations: | St. Raphael's Dialysis Center, New Haven, Connecticut, 06511, United States|North Haven Dialysis, North Haven, Connecticut, 06473, United States|Irving Place Dialysis Center, New York, New York, 10003, United States|Upper Manhattan Dialysis Clinic (UMDC), New York, New York, 10025, United States |
| URL: | https://clinicaltrials.gov/show/NCT01427907 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|